ATLANTA, Jan. 21, 2025 /PRNewswire/ — MetroCity Bankshares, Inc. (“MetroCity” or the “Company”) (NASDAQ: MCBS), holding company for Metro City Bank (the “Bank”), today reported net income of $16.2 million, or $0.63 per diluted share, for the fourth quarter of 2024, compared to $16.7…
Tag: PR Newswire
Company to Build on Industry Leadership Established Through Market-Leading Growth Achieved During Partnership with NexPhase NEW YORK, Jan. 21, 2025 /PRNewswire/ — NexPhase Capital, LP (“NexPhase” or “NPC”), a thematically driven and operationally focused private equity firm, today…
Company to Build on Industry Leadership Established Through Market-Leading Growth Achieved During Partnership with NexPhase NEW YORK, Jan. 21, 2025 /PRNewswire/ — NexPhase Capital, LP (“NexPhase” or “NPC”), a thematically driven and operationally focused private equity firm, today…
TSX: MFI www.mapleleaffoods.com MISSISSAUGA, ON, Jan. 21, 2025 /PRNewswire/ – Maple Leaf Foods Inc. (“Maple Leaf Foods” or the “Company”) (TSX: MFI) announced today that it will be participating in the 28th Annual CIBC Western Institutional Investor Conference being held in Whistler,…
TSX: MFI www.mapleleaffoods.com MISSISSAUGA, ON, Jan. 21, 2025 /PRNewswire/ – Maple Leaf Foods Inc. (“Maple Leaf Foods” or the “Company”) (TSX: MFI) announced today that it will be participating in the 28th Annual CIBC Western Institutional Investor Conference being held in Whistler,…
COPENHAGEN, Denmark, Jan. 21, 2025 /PRNewswire/ — Cmbio™, a global leader in multi-omics science and digital biology, announces a strategic partnership with Nimble Science, to deliver first in class high-quality, multi-omic data insights from the small intestine. Through this initiative,…
COPENHAGEN, Denmark, Jan. 21, 2025 /PRNewswire/ — Cmbio™, a global leader in multi-omics science and digital biology, announces a strategic partnership with Nimble Science, to deliver first in class high-quality, multi-omic data insights from the small intestine. Through this initiative,…
HOUSTON, Jan. 21, 2025 /PRNewswire/ — IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its CRISPR-Tuberculosis (TB) Blood Test. This test is the…
HOUSTON, Jan. 21, 2025 /PRNewswire/ — IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its CRISPR-Tuberculosis (TB) Blood Test. This test is the…
Research conducted in partnership with Ipsos introduces a new paradigm in leveraging psychographic insights to influence consumer financial behaviors. NEW YORK, Jan. 21, 2025 /PRNewswire/ — The financial services industry is experiencing a transformation, thanks to a recent study by…